These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 1379701

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.
    Xie Z, Lu S, Li H.
    Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS.
    Am Fam Physician; 2000 Aug 15; 62(4):825-32, 837-8. PubMed ID: 10969860
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR, Morris TC, Owen J, Stringer JS.
    Am J Obstet Gynecol; 2004 Mar 15; 190(3):721-9. PubMed ID: 15042005
    [Abstract] [Full Text] [Related]

  • 32. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Bowers GB.
    N Engl J Med; 1992 Aug 27; 327(9):588-93. PubMed ID: 1379344
    [Abstract] [Full Text] [Related]

  • 33. Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study.
    Shaw SW, Lin SY, Lin CH, Su YN, Cheng PJ, Lee CN, Chen CP.
    Taiwan J Obstet Gynecol; 2010 Mar 27; 49(1):30-4. PubMed ID: 20466289
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, Baumgarten A.
    Am J Obstet Gynecol; 1999 Oct 27; 181(4):929-33. PubMed ID: 10521756
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin GM, Mueenuddin M, Bombard A.
    Am J Obstet Gynecol; 1995 Oct 27; 173(4):1306-9. PubMed ID: 7485343
    [Abstract] [Full Text] [Related]

  • 39. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ, Kennard A.
    Curr Opin Obstet Gynecol; 1992 Apr 27; 4(2):302-7. PubMed ID: 1373963
    [Abstract] [Full Text] [Related]

  • 40. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
    Bahado-Singh RO, Oz AU, Kovanci E, Deren O, Copel J, Baumgarten A, Mahoney J.
    Am J Obstet Gynecol; 1998 Dec 27; 179(6 Pt 1):1627-31. PubMed ID: 9855608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.